Swiss company Sophia Genetics works with artificial intelligence to aid medical professionals diagnose and treat patients through genomic analysis. Their AI is already used in 300 hospitals across 53 countries, and “the most advanced artificial intelligence AI for data-driven medicine,” according to the company.
Now, Sophia Genetics has raised $30 million in funding to continue saving lives.
“Sophia acts as a real disruptor by breaking down the information silos in health care, meaning that the information from a patient in London or Paris can, for instance, help better diagnose and treat a patient in Lagos or Rio,” Sophia Genetics CEO and cofounder Dr. Jurgi Camblong says.
Digital TrendsWhy not share this article?
